A clinical trial listing related to kisspeptin research was updated on October 5, 2026. The study, titled "The Impact of Time-restricted Eating on the Outcomes Associated With Polycystic Ovary Syndrome (Polyendocrine Metabolic Ovarian Syndrome)," is registered under identifier NCT06204965.
The trial's current status is listed as not yet recruiting. No phase is assigned to this study, with the phase field marked as not applicable.
As a trial still in the not yet recruiting stage, no participant enrollment has begun and no outcomes have been reported. Kisspeptin remains classified as an unapproved compound used only in research settings. No results, efficacy data, or safety findings are included in this update, since the study has not progressed to an active recruitment or data collection phase.
This listing reflects only the administrative status of the trial as registered on ClinicalTrials.gov. Further updates may follow as the study progresses toward recruitment and data collection. Readers interested in the broader context of kisspeptin research can consult the compound overview for additional background information.